Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zilli

Showing results (21-30 of 234) with videos related to

Pageof 24
Sort By:
European Urology|January 21, 2017
Re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267-73Thomas Zilli, Gilles Créhange, Olivier Chapet, et al.
European Radiology|October 28, 2024
Prostate MRI: bridging radiology and radiation oncology for precision radiation therapyAndrea Lancia, Gianluca Ingrosso, Thomas Zilli
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
Re: Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer's Disease (AD)Valentina Garibotto, Giovanni B Frisoni, Thomas Zilli
JAMA Oncology|August 8, 2024
Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?Nicolas Benziane-Ouaritini, Thomas Zilli, Paul Sargos
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Optimizing prostate cancer stereotactic body radiotherapy: margins, dose, or target volume-de-intensification?Jennifer Le Guevelou, Paul Sargos, Thomas Zilli
Frontiers in Oncology|December 9, 2017
Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate CancerAlan Dal Pra, Thomas Zilli, Stephane Supiot
European Urology|October 3, 2020
Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9Vérane Achard, Alan Dal Pra, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics|April 15, 2022
Intraprostatic Urethra: The New Kid on the Block for Prostate Cancer Radiation Therapy?Thomas Zilli, Vérane Achard, Jennifer Le Guevelou
Cancer Treatment Reviews|November 28, 2017
Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?Cristina Picardi, Ioan Perret, Raymond Miralbell, et al.
The Lancet. Oncology|December 1, 2022
Five fractions of SBRT for prostate cancerVérane Achard, Davide Bosetti, Gianfranco Pesce, et al.
Pageof 24

Showing results (21-30 of 234) with videos related to

Sort By:
Pageof 24
European Urology|January 21, 2017
Re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267-73Thomas Zilli, Gilles Créhange, Olivier Chapet, et al.
European Radiology|October 28, 2024
Prostate MRI: bridging radiology and radiation oncology for precision radiation therapyAndrea Lancia, Gianluca Ingrosso, Thomas Zilli
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
Re: Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer's Disease (AD)Valentina Garibotto, Giovanni B Frisoni, Thomas Zilli
JAMA Oncology|August 8, 2024
Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?Nicolas Benziane-Ouaritini, Thomas Zilli, Paul Sargos
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Optimizing prostate cancer stereotactic body radiotherapy: margins, dose, or target volume-de-intensification?Jennifer Le Guevelou, Paul Sargos, Thomas Zilli
Frontiers in Oncology|December 9, 2017
Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate CancerAlan Dal Pra, Thomas Zilli, Stephane Supiot
European Urology|October 3, 2020
Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9Vérane Achard, Alan Dal Pra, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics|April 15, 2022
Intraprostatic Urethra: The New Kid on the Block for Prostate Cancer Radiation Therapy?Thomas Zilli, Vérane Achard, Jennifer Le Guevelou
Cancer Treatment Reviews|November 28, 2017
Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?Cristina Picardi, Ioan Perret, Raymond Miralbell, et al.
The Lancet. Oncology|December 1, 2022
Five fractions of SBRT for prostate cancerVérane Achard, Davide Bosetti, Gianfranco Pesce, et al.
Pageof 24